Chronic Lymphocytic Leukemia [clinicaltrials_resource:6fa5e387c6b7afb7dba41ecf6a2e4089]
clinicaltrials:NCT00001586Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [clinicaltrials:NCT00001637]Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00021749]Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia [clinicaltrials:NCT00022880]clinicaltrials:NCT00022971Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [clinicaltrials:NCT00036023]Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00036257]A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies [clinicaltrials:NCT00038025]CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation [clinicaltrials:NCT00038818]clinicaltrials:NCT00038831Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer [clinicaltrials:NCT00039676]Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00046488]Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients [clinicaltrials:NCT00058656]Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia [clinicaltrials:NCT00060424]clinicaltrials:NCT00071396A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00073489]Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00078234]clinicaltrials:NCT00081887Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00086203]clinicaltrials:NCT00090051HuMax-CD20 in Chronic Lymphocytic Leukemia [clinicaltrials:NCT00093314]A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013) [clinicaltrials:NCT00100152]Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [clinicaltrials:NCT00100711]Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00102661]Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00103558]Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [clinicaltrials:NCT00104858]Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy [clinicaltrials:NCT00108108]Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia [clinicaltrials:NCT00109356]Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. [clinicaltrials:NCT00131313]Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. [clinicaltrials:NCT00145652]Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00151736]Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel [clinicaltrials:NCT00159003]Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy [clinicaltrials:NCT00183950]Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [clinicaltrials:NCT00193518]Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma [clinicaltrials:NCT00201682]A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated [clinicaltrials:NCT00233506]Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00234481]clinicaltrials:NCT00254410
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT01790568 [clinicaltrials_resource:5f2c92cfa9a471794368c902669d341e]eligibility for clinicaltrials:NCT01244906 [clinicaltrials_resource:8c4e696851d5bbcaad5a2f6b13bf803f]eligibility for clinicaltrials:NCT00093314 [clinicaltrials_resource:ffa8bc4fb71b4691a7c8b5d3049bdc2a]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01790568 [clinicaltrials_resource:5f2c92cfa9a471794368c902669d341e]eligibility for clinicaltrials:NCT01244906 [clinicaltrials_resource:8c4e696851d5bbcaad5a2f6b13bf803f]eligibility for clinicaltrials:NCT00093314 [clinicaltrials_resource:ffa8bc4fb71b4691a7c8b5d3049bdc2a]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Chronic Lymphocytic Leukemia [clinicaltrials_resource:6fa5e387c6b7afb7dba41ecf6a2e4089]
Bio2RDF identifier
6fa5e387c6b7afb7dba41ecf6a2e4089
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6fa5e387c6b7afb7dba41ecf6a2e4089
identifier
clinicaltrials_resource:6fa5e387c6b7afb7dba41ecf6a2e4089
title
Chronic Lymphocytic Leukemia
@en
type
label
Chronic Lymphocytic Leukemia [clinicaltrials_resource:6fa5e387c6b7afb7dba41ecf6a2e4089]
@en